Drug Profile
Tocilizumab biosimilar - Celltrion
Alternative Names: CT-P47Latest Information Update: 01 Feb 2024
Price :
$50
*
At a glance
- Originator Celltrion
- Class Anti-inflammatories; Antineoplastics; Antirheumatics; Immunotherapies; Monoclonal antibodies; Skin disorder therapies; Vascular disorder therapies
- Mechanism of Action Interleukin 6 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration Rheumatoid arthritis